July 17, 2026
Thinking About a GLP-1? What You Should Know Before You Start
If you are reading this, there is a good chance you are considering one of the newer GLP-1 medications—perhaps semaglutide, tirzepatide, Wegovy, Zepbound, or what many people simply refer to as “Ozempic.” You may also feel overwhelmed by the amount of conflicting information surrounding them.
One person says the medication changed her life. Another says it made him miserable. Social media is filled with dramatic before-and-after photographs, while news reports focus on side effects, lawsuits, counterfeit products, and weight regain. At the same time, online companies promise inexpensive injections shipped directly to your door after only a brief questionnaire.
It is understandable that people are unsure what—or whom—to believe.
Over the past year, few topics have generated more questions in my practice than GLP-1 medications. Rather than answer those questions one patient at a time, I decided to create this series. My goal is to help you understand not only these medications, but also the broader idea of metabolic health and why thoughtful medical care matters just as much as access to the prescription itself.
Whether or not you ever become a WellCentric patient, I hope these articles help you make more informed and confident decisions about your health.
My Perspective After Decades of Treating Obesity
I have practiced medicine for more than thirty years. Before moving into functional medicine, I spent nearly two decades performing bariatric surgery and caring for patients with severe obesity and the many diseases associated with it. That experience shaped the way I think about weight, metabolism, and long-term health.
I learned early that obesity is not simply a character flaw or the predictable result of poor discipline. I met many patients who worked extraordinarily hard and still struggled with their weight. I also saw how powerfully health could improve when we changed the underlying physiology rather than repeatedly telling people to try harder.
During those years, I watched many supposed weight-loss breakthroughs come and go. Some worked briefly, many disappointed, and a few ultimately proved unsafe. That history has made me appropriately skeptical whenever a new treatment is described as revolutionary.
GLP-1 medications are different.
For the first time in my career, I believe we have medications that can meaningfully alter the biology of obesity—not simply suppress appetite for a few weeks, but influence the physiologic signals that regulate hunger, fullness, food intake, and body weight.
That does not make them magic. It does not make them appropriate for everyone. It certainly does not mean they should be prescribed casually. But I do believe they represent one of the most important advances in obesity medicine that I have seen, and that is precisely why they deserve to be used thoughtfully.
Why These Medications Have Generated So Much Excitement
For decades, most conversations about excess weight began and ended with the same advice: eat less and exercise more. There is truth in that advice, but it ignores a great deal of human physiology.
People who have struggled with weight know the familiar cycle. They lose weight, hunger increases, energy declines, and the body seems determined to regain what was lost. Many eventually conclude that they simply lack discipline. In reality, they may be fighting powerful biologic systems designed to defend body weight.
GLP-1 medications help change some of those signals.
For many patients, the most striking effect is not merely a smaller appetite. It is the quieting of what is often called “food noise”—the constant thinking about food, the repeated negotiation with cravings, and the exhausting sense of fighting one’s own body throughout the day. When that noise recedes, many patients feel a degree of control they have not experienced in years.
That is one reason these medications have generated so much enthusiasm. They have also helped change the cultural conversation around obesity by making it harder to dismiss the condition as a simple failure of willpower.
Why There Is So Much Controversy
The controversy exists because two things can be true at once: these medications can be remarkably effective, and they can also be used poorly.
When I hear about someone having a terrible experience with a GLP-1 medication, my first question is usually not which medication they took. It is how the treatment was managed.
Many of the problems receiving public attention are not simply problems with the drug itself. They may reflect medication prescribed after only a brief questionnaire, rapid dose escalation, poor attention to nutrition, no plan to preserve muscle, minimal follow-up, questionable sourcing, or no meaningful strategy for long-term maintenance.
That is not thoughtful treatment. It is medication access without comprehensive medical care.
The Mistake I Hope Patients Avoid
Most people believe they are shopping for a medication. I do not think that is what they are really choosing.
They are choosing how they want their health managed.
Semaglutide and tirzepatide can be obtained from many sources. Thoughtful, physician-guided metabolic care is harder to find. The medication is only one part of a successful treatment plan. Equally important are understanding the factors that contributed to weight gain, selecting the appropriate medication and dose, preserving muscle while losing fat, managing side effects, monitoring metabolic health, and planning for what happens after the initial weight-loss phase.
That is the difference between prescribing and practicing medicine.
The WellCentric Philosophy
At WellCentric, we do not view GLP-1 medications as weight-loss products. We view them as one tool within a broader effort to improve metabolic health.
Weight loss matters. It is often the reason people first seek care, and it should not be minimized. But when I ask patients what they hope weight loss will actually give them, the answers are usually much more meaningful than a number on the scale.
They want more energy, less joint pain, improved mobility, better sleep, fewer medications, lower risk of diabetes and heart disease, greater confidence, and a longer, healthier life. Weight loss can help move them toward those goals, but it is not the final destination.
That is why our focus must be larger than body weight alone.
What This Series Will Cover
Over the next several weeks, I will address the questions patients ask me most often. We will discuss how to choose a GLP-1 program, whether online and compounded medications are safe, what metabolic health actually means, how to preserve muscle during weight loss, whether these medications must be continued indefinitely, and what a good maintenance plan should look like after goal weight is reached.
My hope is not simply that you will understand GLP-1 medications more clearly. I hope you will better understand your own physiology and become more capable of judging the quality of the care being offered to you.
Informed patients make better decisions, and better decisions usually lead to better health.
Next Week
In the next article, I will discuss the questions every patient should ask before choosing a GLP-1 program—whether that program is offered through a physician’s office, an online service, or a medical spa.
Surprisingly few people know what those questions should be.
Considering GLP-1 Therapy?
The WellCentric Metabolic Health Program is built around physician evaluation, thoughtful prescribing, muscle preservation, education, body-
composition monitoring, and long-term metabolic health—not simply access to medication.
